HIF-2α is mostly expressed in CSCs but not in non-CSCs in gliomas and it can induce Oct4, Glut1 and vascular endothelial growth factor (VEGF), thereby promoting CSCs in metabolism, proliferation, survival, and escape from immune surveillance [59]. Here, VEGFA is linked to glioma.